With the Trump administration's flip-flops on tariffs giving the Indian pharma industry a headache, experts feel it's time ...

As the pharmaceutical industry has struggled to address barren pipelines, the patent cliff, regulatory issues and the challenging economic climate, many organizations have set their sights on ...

As per the scheme's terms, the merger will take effect from the first business day of the month following the fulfilment of ...

This Product is indicated for the management of mild to moderate pain in adult and pediatric patients 2 years and older.